Full Text View
Tabular View
Study Results
Related Studies
Study of the Effect of Ivacaftor on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation
This study has been completed.
Study NCT01262352   Information provided by Vertex Pharmaceuticals Incorporated

First Received on December 15, 2010.   Last Updated on February 4, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial